Communiqués 908 Devices Inc.

Actions

MASS

US65443P1021

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 29/09/2026			Varia. 5j.	Varia. 1 janv.
11,85 ^USD	+1,63%		+5,99%	+125,71%

17/09	Un dirigeant de 908 Devices vend des actions pour une valeur de 280 070 dollars, selon un récent dépôt auprès de la SEC	MT
10/09	908 Devices Inc. : Canaccord Genuity toujours positif	ZM

Communiqués

01/09	908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium	BU
12/08	908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference	BU
11/08	908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook	BU
29/07	908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference	BU
28/07	908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026	BU
02/06	908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	BU
28/05	908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference	BU
06/05	Investor presentation (05/06/2026 00:00:00)	PU
06/05	908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook	BU
06/05	908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio	BU
04/05	908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026	AQ
01/05	908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026	BU
21/04	908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	BU
10/04	908 Devices : Your Gas Meter Didn’t Get Replaced—It Got Smarter	PU
16/03	908 Devices to Present at the Sidoti Small Cap Conference	BU
03/03	908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook	BU
24/02	908 Devices to Participate in Investor Conferences in March	BU
17/02	908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026	BU
05/02	908 Devices Enhances MX908 Usability and Adds New Drug Targets	BU
20/01	908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025	BU
10/11	Investor presentation (11/10/2025 00:00:00)	PU
10/11	908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook	BU
30/10/25	908 Devices to Participate in Upcoming Investor Conferences	BU
28/10/25	United States Coast Guard Purchases 908 Devices’ Handheld Mass Spec Devices for Chemical Threat Identification	BU
23/10/25	908 Devices to Report Third Quarter 2025 Financial Results on November 10 2025	AQ